v3.26.1
Operating segments (Tables)
 6 Months Ended
Apr. 30, 2026
Segment Reporting [Abstract]  
Segment Reporting, Reconciliation of Profit (Loss) by Segment to Consolidated
The following table presents information about our reportable segments as further reconciled to consolidated GAAP financial results:
Three Months EndedSix Months Ended
April 30, 2026April 30, 2025April 30, 2026April 30, 2025
Sales
Industrial Precision Solutions$350,466 $318,847 $677,327 $619,295 
Medical and Fluid Solutions212,850 202,809 406,033 396,418 
Advanced Technology Solutions177,531 161,282 326,948 282,645 
Total segment sales740,847 682,938 1,410,308 1,298,358 
Adjusted cost of sales
Industrial Precision Solutions(142,315)(127,720)(277,070)(240,867)
Medical and Fluid Solutions(108,167)(101,362)(204,722)(204,731)
Advanced Technology Solutions(85,153)(76,456)(157,182)(131,315)
Total segment adjusted cost of sales(335,635)(305,538)(638,974)(576,913)
Adjusted selling and administrative expenses
Industrial Precision Solutions(90,580)(83,174)(178,330)(163,343)
Medical and Fluid Solutions(33,323)(33,581)(67,585)(68,193)
Advanced Technology Solutions(45,551)(46,997)(91,926)(92,314)
Total segment adjusted selling and administrative expenses(169,454)(163,752)(337,841)(323,850)
Depreciation
Industrial Precision Solutions6,007 5,595 11,962 11,239 
Medical and Fluid Solutions7,833 8,672 15,673 17,376 
Advanced Technology Solutions1,500 1,687 3,087 3,271 
Total segment depreciation15,340 15,954 30,722 31,886 
EBITDA
Industrial Precision Solutions123,578 113,548 233,889 226,324 
Medical and Fluid Solutions79,193 76,538 149,399 140,870 
Advanced Technology Solutions48,327 39,516 80,927 62,287 
Total segment EBITDA251,098 229,602 464,215 429,481 
Inventory step-up amortization(1,135)— (1,135)(3,135)
Acquisition related costs(534)(513)(534)(1,543)
Severance and other— (10,313)— (16,274)
Depreciation and amortization(36,315)(37,578)(72,900)(74,608)
Corporate expenses(15,911)(12,448)(26,038)(24,224)
Interest expense(21,942)(26,572)(45,073)(53,131)
Interest and investment income362 553 752 1,494 
Pension settlement charge(24,049)— (24,049)— 
Other - net(10,400)(3,961)10,437 (2,435)
Income before taxes$141,174 $138,770 $305,675 $255,625 
Schedule of Operating Segments, Long Lived Assets
The following table presents additional information about our reportable segments:
Industrial Precision SolutionsMedical and Fluid SolutionsAdvanced Technology SolutionsCorporateTotal
Three months ended April 30, 2026
Amortization of intangibles$7,552 $9,533 $2,321 $— $19,406 
Property, plant and equipment expenditures2,467 5,479 2,234 — 10,180 
Three months ended April 30, 2025
Amortization of intangibles$7,019 $9,695 $2,983 $— $19,697 
Property, plant and equipment expenditures4,054 2,269 7,851 1,865 16,039 
Six months ended April 30, 2026
Amortization of intangibles15,072 19,204 4,699 — 38,975 
Property, plant and equipment expenditures5,732 10,804 11,002 155 27,693 
Six months ended April 30, 2025
Amortization of intangibles13,828 19,132 6,047 — 39,007 
Property, plant and equipment expenditures13,583 17,181 4,393 2,282 37,439 
As of April 30, 2026
Identifiable assets (1)
1,898,264 2,191,580 772,837 1,101,737 5,964,418 
As of October 31, 2025
Identifiable assets (1)
1,858,974 2,201,528 738,762 1,118,417 5,917,681 
(1) Operating segment identifiable assets include notes and accounts receivable net of allowance for doubtful accounts, inventories net of reserves, property, plant and equipment net of accumulated depreciation and goodwill. Corporate assets are principally cash and cash equivalents, deferred income taxes, leases, headquarter facilities and intangible assets.
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue
We had significant net sales, measured based on their geographic destination, as follows:
Three Months EndedSix Months Ended
April 30, 2026April 30, 2025April 30, 2026April 30, 2025
Net external sales
Americas$308,253 $292,463 $570,183 $560,300 
Europe194,459 172,496 376,920 340,259 
Asia Pacific238,135 217,979 463,205 397,799 
Total net external sales740,847 682,938 1,410,308 1,298,358